Article
Identification of novel candidate autoantibodies in Alzheimer’s disease
1 May 2020
Abstract excerpt
Background and purpose Accumulated failures in Alzheimer’s disease (AD) clinical trials have highlighted an urgent need to identify additional biomarkers involved in AD. Recently, mounting evidence reported that autoantibodies are ubiquitous in human sera. However, it is unknown whether autoantibodies are upregulated in amyloid‐tau biomarker‐confirmed AD. Methods A total of 40 subjects with mild dementia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
